ALK INHIBITORS SAFETY PROFILE IN PEDIATRIC PATIENTS TREATED FOR AN ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA: REAL LIFE EXPERIENCE AMONG A FRENCH COHORT. (October 2022) - d'Hautefeuille, C.; Abbou, S.; El-Gourari-Miaz, L.; Lambilliotte, A.; Renard, C.; Landman-Parker, J.; Gourdon, S.; Metayer, L.; Leblanc, T.; Pacquement, H.; Rabian, F.; Verschuur, A.; et al.